Search Results

Everolimus 200 mg  | 99.52%

TargetMol

Everolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.

More Information Supplier Page

Everolimus 50 mg  | 99.52%

TargetMol

Everolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.

More Information Supplier Page

Everolimus 25 mg  | 99.52%

TargetMol

Everolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.

More Information Supplier Page

Intepirdine 25 mg  | Purity Not Available

TargetMol

SB742457 is a highly selective 5-HT6 receptor antagonist, used in trials studying the treatment of Alzheimer’s Disease.

More Information Supplier Page

Balipodect 25 mg  | 99.28%

TargetMol

Balipodect (TAK063) is a highly effective and selective PDE10A inhibitor (IC50: 0.30 nM); Its selectivity is >15000-fold over other PDEs.

More Information Supplier Page

Caspofungin Acetate 10 mg  | Purity Not Available

TargetMol

Cancidas is the acetate salt of an antimycotic echinocandin lipopeptide, semisynthetically derived from a fermentation product of the fungus Glarea lozoyensis. This agent is active against Aspergillus and Candida species.

More Information Supplier Page

SR9243 25 mg  | 99.03%

TargetMol

SR9243, an LXR inverse agonist, can induce LXR-corepressor interaction; shows anticancer activity and selectively targets the lipogenesis and Warburg effect.

More Information Supplier Page

PH-797804 2 mg  | 97.79%

TargetMol

PH-797804 is a pyridinone inhibitor of p38α (IC50: 26 nM, in a cell-free assay); 4-fold more selective versus p38β and does not inhibit JNK2.

More Information Supplier Page